Minims Pilocarpinenitraat Bausch + Lomb Ireland Limited (Pilocarpine Nitrate)

Pilocarpine nitrate, the active ingredient in Minims Pilocarpinenitraat Bausch + Lomb Ireland Limited, is a muscarinic agonist presented as an ophthalmic preparation for ocular use. It belongs to the glaucoma treatment class and works to lower intra‑ocular pressure in patients with glaucoma or ocular hypertension.

GNH USA supplies Minims Pilocarpinenitraat Bausch + Lomb Ireland Limited as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution across EU and other regulated markets, and meets all applicable regulatory standards.

Pilocarpine nitrate is used in the management of ocular conditions that involve elevated intra‑ocular pressure.

- Glaucoma: reduces intra‑ocular pressure by increasing aqueous humor outflow. - Ocular hypertension: lowers pressure to prevent progression to glaucoma. - Post‑operative ocular inflammation: facilitates fluid drainage and stabilizes pressure.

Pilocarpine nitrate may cause ocular and systemic adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Blurred vision: transient difficulty focusing after instillation. - Eye irritation: redness, burning or stinging sensation. - Headache: mild to moderate headache following use. - Brow ache: discomfort around the eyebrow region.

Serious or Rare Side Effects: - Allergic reaction: swelling, rash or severe eye inflammation. - Decreased vision: sudden loss of visual acuity requiring medical attention. - Systemic cholinergic effects: nausea, sweating, or bradycardia.

When prescribing pilocarpine nitrate, clinicians should consider several precautionary measures to ensure safe use.

- Contraindication: avoid in patients with known hypersensitivity to pilocarpine or other muscarinic agonists. - Caution: use carefully in individuals with narrow-angle glaucoma as it may precipitate angle closure. - Monitoring: assess intra‑ocular pressure regularly after initiation. - Systemic effects: watch for signs of cholinergic excess, especially in patients on cholinesterase inhibitors. - Pregnancy: safety not established; weigh potential benefits against risks. - Store at room temperature: keep in original container, protect from light and moisture.

Pilocarpine nitrate can interact with other medications, affecting its efficacy or safety.

Major Interactions (Avoid): - Anticholinergic drugs: may diminish the ocular pressure‑lowering effect. - Systemic cholinesterase inhibitors: risk of additive cholinergic toxicity. - Beta‑blocker eye drops: combined IOP reduction may cause excessive hypotension.

Moderate Interactions (Monitor Closely): - Topical anesthetics: may increase ocular irritation when used together. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): could affect corneal healing. - Systemic antihistamines: may exacerbate dry‑eye symptoms.